Under the agreement, Cellares will use its Cell Shuttle and Cell Q systems to automate TSC-101 manufacturing processes.

Industries all over the world are being changed by the rise of automatic manufacturing jobs. Automation is supposed to make things more efficient and productive. But it also comes with its problems.

Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with ...

In the modern auto manufacturing industry, reducing cost, complexity and environmental impact is paramount. As part of its strategy to keep up, Audi announced that it has gone live with its Edge Cloud ...